Table 1. Oligonucleotides used in the... | American Society of Hematology

Table 1.

Oligonucleotides used in the present study

	Oligonucleotide sequence (5′ to 3′)
1	GCCAAGGACAGGTACGGCTGTCATCACTTAGA^*
2	GCCAAGGACAGGTACGGCTGTCCCCACTTAGA^*
3	GCTAGCCCGGGCTCGAGCGGCTGTCATCACTTAGA^*
4	TAGCCCGGGCTCGAGGACAGGTAGTCATCACTTAGA^*
5	GAAGATCTCTCGAGGACAGGTACGGCTGTCATCACTTAGA
6	GAAGATCTCTCGAGGACAGGTACGGCTGTCCCCACTTAGAC
7	GAAGATCTCTCGAGCGGCTGTCATCACTTAGAC
8	GAAGATCTCTCGAGGACAGGTAGTCATCACTTAGAC
9	CCCAAGCTTGGTACCGGTGTCTGTTTGAGGTTGC
10	CAAGCACAGCAATGCTGAGTCATGATGAGTCATGC^*
11	AGGACAGGTACGGCTGTCATCACTTAGAC^*
12	GCCAAGGACAGGTACGGC^*
13	CTTTAGTGATGGCCTGGCTC
14	GGCAGAATCCAGATGCTCAAG
15	GAGCCTCAGGATCCAGCACAC
16	GATATGTGCTGCTGCCTCTC
17	GAACGTCTGAGATTATCAAT
18	GAAATGGATTGCCAAAACGG
19	GGCGGACTATGACTTAGTTG
20	CTTTTAGGATGGCAAGGGAC
21	CTGGCATTGCCCTCAACGAC
22	GATGGTACATGACAAGGTGC
23	ACGTGCGCGCACCCGGGTTG
24	CTTCATGTGCAAGGCCAGGTG
25	GAAGTCCAACTCCTAAGCCAGTGCCAGAAGGATC
26	CTTCTGGCACTGGCTTAGGAGTTGGACTTCGATC
27	TCCTGGATGTTCAAGAGGG
28	CTTTACCTTCTTCAGTAGATTC

	Oligonucleotide sequence (5′ to 3′)
1	GCCAAGGACAGGTACGGCTGTCATCACTTAGA^*
2	GCCAAGGACAGGTACGGCTGTCCCCACTTAGA^*
3	GCTAGCCCGGGCTCGAGCGGCTGTCATCACTTAGA^*
4	TAGCCCGGGCTCGAGGACAGGTAGTCATCACTTAGA^*
5	GAAGATCTCTCGAGGACAGGTACGGCTGTCATCACTTAGA
6	GAAGATCTCTCGAGGACAGGTACGGCTGTCCCCACTTAGAC
7	GAAGATCTCTCGAGCGGCTGTCATCACTTAGAC
8	GAAGATCTCTCGAGGACAGGTAGTCATCACTTAGAC
9	CCCAAGCTTGGTACCGGTGTCTGTTTGAGGTTGC
10	CAAGCACAGCAATGCTGAGTCATGATGAGTCATGC^*
11	AGGACAGGTACGGCTGTCATCACTTAGAC^*
12	GCCAAGGACAGGTACGGC^*
13	CTTTAGTGATGGCCTGGCTC
14	GGCAGAATCCAGATGCTCAAG
15	GAGCCTCAGGATCCAGCACAC
16	GATATGTGCTGCTGCCTCTC
17	GAACGTCTGAGATTATCAAT
18	GAAATGGATTGCCAAAACGG
19	GGCGGACTATGACTTAGTTG
20	CTTTTAGGATGGCAAGGGAC
21	CTGGCATTGCCCTCAACGAC
22	GATGGTACATGACAAGGTGC
23	ACGTGCGCGCACCCGGGTTG
24	CTTCATGTGCAAGGCCAGGTG
25	GAAGTCCAACTCCTAAGCCAGTGCCAGAAGGATC
26	CTTCTGGCACTGGCTTAGGAGTTGGACTTCGATC
27	TCCTGGATGTTCAAGAGGG
28	CTTTACCTTCTTCAGTAGATTC

Sequences of the positive strands of the double-stranded oligonucleotides were used in this study.